Complex Versus Noncomplex Percutaneous Coronary Intervention With Newer-Generation Drug-Eluting Stents: An Analysis From the Randomized BIOFLOW Trials

被引：0

作者：

Hemetsberger, Rayyan ^{[1
]}

Abdelghani, Mohammad ^{[2
]}

Toelg, Ralph ^{[3
]}

Garcia-Garcia, Hector ^{[4
]}

Farhan, Serdar ^{[5
]}

Elbasha, Karim ^{[1
]}

Allali, Abdelhakim ^{[6
]}

Windecker, Stephan ^{[7
]}

Lefevre, Thierry ^{[8
]}

Saito, Shigeru ^{[9
]}

Kandzari, David ^{[10
]}

Waksman, Ron ^{[11
]}

Richardt, Gert ^{[12
]}

机构：

[1] Segeberger Kliniken, Bad Segeberg, Germany

[2] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands

[3] Herzzentrum Segeberger Kliniken GmbH, Bad Segeberg, Germany

[4] Washington Hosp Ctr, Chevy Chase, MD USA

[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[6] Heart Ctr Bad Segeberg, Bad Segeberg, Germany

[7] Swiss Cardiovasc Ctr Bern, Bern, Switzerland

[8] Inst Hosp Jacques Cartier, Massy, France

[9] Shonankamakura Gen Hosp, Kamakura, Kanagawa, Japan

[10] Piedmont Heart Inst, Atlanta, GA USA

[11] MedStar Heart Inst, Washington, DC USA

[12] Segeberger Kliniken, Ctr Heart, Bad Segeberg, Germany

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 78卷 / 19期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-115

引用

页码：B48 / B49

页数：2

共 50 条

[1] Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
Hemetsberger, Rayyan
Abdelghani, Mohammad
Toelg, Ralph
Garcia-Garcia, Hector M.
Farhan, Serdar
Mankerious, Nader
Elbasha, Karim
Allali, Abdelhakim
Windecker, Stephan
Lefevre, Thierry
Saito, Shigeru
Kandzari, David
Waksman, Ron
Richardt, Gert
CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (07) : 795 - 805
[2] Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
Rayyan Hemetsberger
Mohammad Abdelghani
Ralph Toelg
Hector M. Garcia-Garcia
Serdar Farhan
Nader Mankerious
Karim Elbasha
Abdelhakim Allali
Stephan Windecker
Thierry Lefèvre
Shigeru Saito
David Kandzari
Ron Waksman
Gert Richardt
Clinical Research in Cardiology, 2022, 111 : 795 - 805
[3] Patients With Moderate to Severe Lesion Tortuosity Undergoing Coronary Intervention With Newer-Generation Drug Eluting Stents: An Analysis From the Randomized BIOFLOW Trials
Hemetsberger, Rayyan
Toelg, Ralph
Abdelghani, Mohammad
Farhan, Serdar
Garcia-Garcia, Hector Manel
Allali, Abdelhakim
Windecker, Stephan
Lefevre, Thierry
Saito, Shigeru
Kandzari, David
Waksman, Ron
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B143 - B143
[4] Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
Rayyan Hemetsberger
Nader Mankerious
Ralph Toelg
Mohammad Abdelghani
Serdar Farhan
Hector M. Garcia-Garica
Abdelhakim Allali
Stephan Windecker
Thierry Lefèvre
Shigeru Saito
David Kandzari
Ron Waksman
Gert Richardt
Clinical Research in Cardiology, 2023, 112 : 1278 - 1287
[5] Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
Hemetsberger, Rayyan
Mankerious, Nader
Toelg, Ralph
Abdelghani, Mohammad
Farhan, Serdar
Garcia-Garica, Hector M.
Allali, Abdelhakim
Windecker, Stephan
Lefevre, Thierry
Saito, Shigeru
Kandzari, David
Waksman, Ron
Richardt, Gert
CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (09) : 1278 - 1287
[6] Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease Meta-Analysis of Randomized Trials
Bangalore, Sripal
Toklu, Bora
Patel, Neil
Feit, Frederick
Stone, Gregg W.
CIRCULATION, 2018, 138 (20) : 2216 - 2226
[7] Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents-an analysis from the randomized BIOFLOW trials
Hemetsberger, R.
Mankerious, N.
Toelg, R.
Abdelghani, M.
Farhan, S.
Garcia-Garcia, H.
Allali, A.
Windecker, S.
Lefevre, T.
Saito, S.
Kandzari, D.
Waksman, R.
Richardt, G.
WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S447 - S447
[8] Response by Bangalore to Letter Regarding Article, "Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials"
Bangalore, Sripal
CIRCULATION, 2019, 139 (17) : 2083 - 2084
[9] Percutaneous Coronary Intervention for Very Small Vessels With the Use of a Newer-Generation 2.0 mm Drug-Eluting Stent
Jen, Hsu-Lung
Wang, Yao-Chang
Tsao, Tien-Ping
Yin, Wei-Hsian
JOURNAL OF INVASIVE CARDIOLOGY, 2021, 33 (07): : E565 - E574
[10] Impact of Chronic Kidney Disease on Clinical Outcomes in Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Era of Newer-Generation Drug-Eluting Stents
Kim, Su-Min
Tripathy, Dipti Ranjan
Park, Sang Wook
Park, Bonil
Son, Jung-Woo
Lee, Jun-Won
Youn, Young Jin
Ahn, Sung-Gyun
Ahn, Min Soo
Kim, Jang-Young
Yoo, Byung-Su
Lee, Seung-Hwan
Yoon, Junghan
KOREAN CIRCULATION JOURNAL, 2017, 47 (02) : 222 - 230

← 1 2 3 4 5 →